Treatment of laryngeal cancer: the permanent challenge

References

• Remade M, Eckel HE, Antonelli A et al Endoscopic cordectomy. Proposal for a classification by the Working Committee, European Laryngological Society. Eur. Arch. Otorhinolaryngol 257,227–231 (2000).
   PubMed Web of Science ®Google Scholar
• Ambrosch P, Kron M, Steiner W Carbon dioxide laser microsurgery for early supraglottic carcinoma. Ann. Otol Rhinol. Laryngol 107(8), 680–688 (1998).
   Google Scholar
• Iro H, Waldfahrer F, Altendorf-Hofmann A, Weidenbrecher M, Sauer R, Steiner W Transoral laser surgery of supraglottic cancer. Arch. Otolaryngol Head Neck Surg. 124,1245–1250 (1998).
   PubMedGoogle Scholar
• Rudert HH, Werner JA, Höft S. Transoral carbon dioxide laser resection of supraglottic carcinoma. Ann. Otol Rhinol. Laryngol 108,819–827 (1999).
   PubMed Web of Science ®Google Scholar
• Eckel I11 I, Thumfart W Jungehulsing M, Sittel C, Stennert E. Transoral laser surgery for early glottic carcinoma. Eur Arch. Otorhinolaryngol 257(4), 221–226 (2000).
   Google Scholar
• Peretti G, Nicolai P, Piazza C, Redaelli de Zinis LO, Valentini S, Antonelli AR. Oncological results of endoscopic resection of Tis and Ti glottic carcinomas by carbon dioxide laser. Ann. Otol Rhino]. Laryngol 110,828–825 (2001).
   Google Scholar
• Gallo A, de Vicentiis M, Mancioco V, Simonelli M, Fiorella ML, Shah JR CO2 laser cordectomy for early-stage glottic carcinoma: a long-term follow-up of 156 cases. Laryngoscope 112(2), 370–374 (2002).
   Google Scholar
• Shvero J, Koren R, Zohar L et al. Laser surgery for the treatment of glottic carcinomas. Ainj Otolaryngol 24(1), 28–33 (2003).
   PubMed Web of Science ®Google Scholar
• Pradhan SA, Pai PS, Neel" SI, D'Cruz AK. Transoral laser surgery for early glottic cancers. Arch. Otolaryngol Head Neck Surg. 129(6), 623–625 (2003).
   Google Scholar
• Peretti G, Piazza C, Balzanelli C, Cantarella G, Nicoali P Vocal outcome after endoscopic cordectomies for Tis and Ti glottic carcinomas. Ann. Otol Rhino]. Laryngol 112,174–179 (2003).
   PubMed Web of Science ®Google Scholar
• Peretti G, Piazza C, Balzanelli C, Mensi MC, Rossini M, Antonelli AR. Preoperative and postoperative voice in Tis—Ti glottic cancer treated by endoscopic cordectomy: an additional issue for patient counseling. Ann. Otol Rhino]. Laryngol 112,759–763 (2003).
   PubMed Web of Science ®Google Scholar
• Gregoire V, Hamoir M, Rosier JF et al Cost-minimization analysis of treatment options for T1NO glottic squamous cell carcinoma: comparison between external radiotherapy, laser microsurgery and partial laryngectomy. Racliother. Oncol 53,1–13 (1999).
   Google Scholar
• Brandenburg JH. Laser cordotomy versus radiotherapy: an objective cost analysis. Ann. Otol Rhino]. Laryngol 110,312–318 (2001).
   PubMed Web of Science ®Google Scholar
• Quer M, Leon X, Orus C, Venegas P, Lopez M, Burgues J. Endoscopic laser surgery in the treatment of radiation failure of early laryngeal carcinoma. Head Neck 22(5), 520–523 (2000).
   PubMed Web of Science ®Google Scholar
• de Gier III I, Knegt PP, de Boer MF, Meeuwis CA, van der Velden LA, Kerrebijn JD. CO2-laser treatment for recurrent glottic carcinoma. Head Neck 23(3), 177–180 (2001).
   Google Scholar
• Vilaseca-Gonzalez I, Bernal-Sprekelsen M, Blanch-Alejandro JL, Moragas-Lluis M. Complications in transoral CO2 laser surgery for carcinoma of the larynx and hypopharynx. Head Neck. 25,382–388 (2003).
   PubMed Web of Science ®Google Scholar
• •References [2-16] provide detailed information on reliability of laser CO2 surgery in early supraglottic cancer [2-4], and early glottic cancer [5-11], providing both excellent local control rates [2-11], and functional results [2,10,11], with low morbidity. Laser CO2 surgery may also be offered to more advanced stages [3,4,16], but requires a strong selection of patients [3,4] and expertise [4,16]. Finally, this surgery is cost effective when compared with open surgery or irradiation [5,7,12,13], and may be proposed for salvage [14,15].
   Google Scholar
• Lefebvre JL, Chevalier D. Supracricoid partial laryngectomy. In: Advances in Otolaryngology — Head and Neck Surgery Volume 12 Myers E (Ed.), Mosby, MO, USA, 1–15 (1998).
   Google Scholar
• Brasnu DE Supracricoid partial laryngectomy with cricohyoidopexy in the management of laryngeal carcinoma. World Surg. 27(7), 817–823 (2003).
   Google Scholar
• Lima RA, Freitas EQ, Kligerman J et al Supracricoid partial laryngectomy with CHEP: functional results and outcome. Otolaryngol Head Neck Surg. 124(3), 258–260 (2001).
   Google Scholar
• Marioni G, Marchese-Ragona R, Ottaviano G, Staffieri A. Supracricoid partial laryngectomy: is it time to define guidelines to evaluate functional results? A review. A/17. Otolaryngol 25(2), 98–104 (2004).
   Google Scholar
• Weinstein GS, El-Sawy MM, Ruiz C et al Laryngeal preservation with supracricoid partial laryngectomy results in improved quality of life when compared with total laryngectomy. Laryngoscope 111 (2), 191–199 (2001).
   PubMed Web of Science ®Google Scholar
• Spriano G, Pellini R, Romano G, Muscatello L, Roselli R. Supracricoid partial laryngectomy as salvage surgery after irradiation failure. Head Neck 24(8), 759–765 (2002).
   PubMed Web of Science ®Google Scholar
• Yiotakis J, Stavroulaki P, Nikopoulos T et al Partial laryngectomy after irradiation failure. Otolaryngol Head Neck Sorg 128(2), 200–209 (2003).
   PubMed Web of Science ®Google Scholar
• •References [17-23] provide information on techniques and indications for supraglottic partial laryngectomies insuring good local control [17,18]. This surgery provides good functional results [19,20] and quality of life [21], and may be used for salvage [22,23].
   Google Scholar
• Parsons JT, Mendenhall WM, Stringer SP, Cassisi NJ, Million RR. Twice-a-day radiotherapy for squamous cell carcinoma of the head and neck: the University of Florida experience. Head Neck 15(2), 87–95 (1993).
   PubMed Web of Science ®Google Scholar
• Dische S, Saunders M, Barrett A, Harvey A, Gibson D, Parmar M. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Rachother Oncol 44,123–136 (1997).
   PubMed Web of Science ®Google Scholar
• Le QTX, Fu KK, Kroll S et al Influence of fraction size, total dose and overall time on local control for T1—T2 glottic carcinoma. Int.j Racliat. Oncol Biol. Phys. 39, 115–126 (1997).
   Google Scholar
• Fu KK, Pajak TF, Troth A et al A radiation Therapy Oncology Group (RTOG) Phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int. Racliat. arca Biol. Phys. 48(1), 7–16 (2000).
   Google Scholar
• Garden AS, Forster K, Wong PF et al Results of radiotherapy for T2NO glottic carcinoma: does the '2' stand for twice-daily treatment? Int. J. Racliat. Oiled Biol. Phys. 55(2), 322–328 (2003).
   Google Scholar
• •References [24-28] support a better local control achieved by hyperfractionation and/or acceleration of definitive irradiation.
   Google Scholar
• Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous cell carcinoma: three meta-analyses of updated individual data. MAHC-NC Collaborative Group. Lancet 355,949–955 (2000).
   PubMed Web of Science ®Google Scholar
• •Large meta-analysis that assessed the impact of either induction, adjuvant, or concurrent chemotherapy. A 4% benefit in survival is obtained with chemotherapy. The only significant survival is provided by concurrent chemotherapy.
   Google Scholar
• Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J. Merl 324,1685–1690 (1991).
   PubMed Web of Science ®Google Scholar
• Richard JM, Sancho-Gamier H, Pessey JJ et al Randomized trial of induction chemotherapy in larynx carcinoma. Eur Cancer34, 224–228 (1998).
   Google Scholar
• Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Shamoud T for the EORTC Head and Neck Cancer Co-operative Group. Larynx preservation in pyriform sinus cancer. Preliminary results of a European Organization for research and Treatment of Cancer Phase III trial. J. Natl Cancer Inst. 88,890–899 (1996).
   Google Scholar
• •References [30-32] are randomized trials based on the same concept of selection by induction chemotherapy of potentially good candidates for irradiation. A nonsignificant loss of 6% in survival was balanced by a 60% rate of larynx preservation in the experimental arms. This approach has been considered as acceptable and safe.
   Google Scholar
• Laccourreye 0, Veivers D, Hans S, Menard M, Brasnu D, Laccourreye H. Chemotherapy alone with curative intent in patients with invasive squamous cell carcinoma of the pharyngolarynx classified as T1—T4NOMO complete clinical responders. Cancer 92(6), 1504–1511 (2001).
   Google Scholar
• Forastiere AA, Goepfert H, Maor M et al Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J. Merl 349(22), 2091–2098 (2003).
   Google Scholar
• •Preliminary analysis of this three-arm randomized trial has failed to find a difference in survival between the three approaches, but the estimate of larynx preservation was significantly higher in the concurrent arm. It must be underscored that two-thirds of the patients had supraglottic cancer and that only tumors defined as T4 on a CT scan (and not clinically) were considered eligible.
   Google Scholar
• Mantz CA, Vokes EE, Kies MS et al. Sequential induction chemotherapy and concomitant chemoradiotherapy in the management of locoregionally advanced laryngeal cancer. Ann. Oncol 12 (3), 343–347 (2001).
   PubMed Web of Science ®Google Scholar